Networks of Centres of Excellence of Canada
Government of Canada

Common menu bar links

Private Sector Advisory Board (PSAB)

The Private Sector Advisory Board (PSAB) is a body of high-level, seasoned and respected individuals from a variety of sectors who understand the national and international challenges associated with Canada’s R&D and commercialization landscape. PSAB was established by the Networks of Centres of Excellence at the request of the Government of Canada in 2007.

PSAB provides the NCE Steering Committee with expert advice and recommendations during the Centres of Excellence for Commercialization and Research (CECR) and Business-Led Networks of Centres of Excellence (BL-NCE) competition processes. PSAB evaluates proposals based on their ability to create a strategic, long-term economic advantage for Canada.

Members

Vikas Arora

Vikas Arora

Vikas Arora was nominated EXFO's Chief Technology Officer in July 2008. He is responsible for the company's technological direction, specifically strategic technology and business initiatives covering next-generation fixed mobile converged networks, 3G/LTE, IMS, SDN/NFV, mobile backhaul, optical networks, Carrier Ethernet/IP and services like VoLTE, video, voice and data. Prior to joining EXFO, Mr. Arora was Co-Founder and Chief Technology Officer of iPine Networks (acquired by Nakina Systems), which offered IP service assurance products for voice, video and data. He served as CTO of Nakina Systems and also spent 10 years at Nortel in Ottawa and Harlow (UK), where he held senior management and architect positions. Overall, Mr. Arora has over 20 years of technical and business leadership experience working with mobile and fixed network operators, system integrators and equipment vendors globally. In 2004, he was named by the editors of the Ottawa Business Journal to its annual "Forty Under 40" list as one of the region's best and brightest business and civic leaders. Mr. Arora also serves on the advisory board of the Information and Communications Technologies Sector of the Department of Foreign Affairs, Trade and Development Canada. He holds a Bachelor of Technology from G.B. Pant University in India and a Master of Science (Computer Science) from the University of Saskatchewan.

Luis Barreto

Luis Barreto

Luis Barreto has 30 years of experience in academia, public health and industry. Dr Barreto is currently the President of the consultancy Dr Luis Barreto and Associates. He is the former Vice-President of Clinical and Medical Affairs and Vice-President of Immunization and Science Policy at Sanofi Pasteur where he spent more than 23 years in research and development, leading clinical trials and shaping immunization policy in Canada and around the world. He led the clinical development and commercialization of many vaccines, including technologies such as acellular pertussis, Haemophilus influenzae type b and polio combinations for children, adolescents and adults. These vaccines bring over a billion dollars yearly in sales back to the Canadian economy and reduce disease and death around the world. He has been an influential member of the Canadian vaccine landscape for over 25 years. He has published extensively on History of Vaccine Development and Canada’s contribution to global control of Small Pox and Polio as well as Clinical Trials and Immunisation Policy.Dr. Barreto has been part of the Canadian pandemic influenza vaccine scientific advisory groups led by the Canadian Institutes of Health Research Institute of Infection and Immunity, and the Chief Public Health Officer of Canada . He has also been part of Health Canada’s Policy Advisory Committee Dr Barreto is a member of various boards including Research Canada, PREVENT, VIDO/InterVac (ex-Chair). InterVac is a $140 million, 150,000 sq ft animal/human vaccine facility opened September 2011 in Saskatchewan. Dr Barreto is a member of the Board of the International Consortium of Antivirals. He has also been appointed as the member of the Policy and Public Support working group of the Decade of Vaccines of the Gates Foundation, Senior Advisor to the National Research, Canada, Vaccine Group and Biosciences Education Canada. Dr. Barreto spends considerable time in philanthropic activities with organizations like Health Partners International and Non-Governmental Organizations. He has been recently appointed to the Board of the March of Dimes. Dr Barreto completed his M.B.B.S and M.D. in Community Medicine in India and M.H.Sc in Community Health and Epidemiology at University of Toronto. He is married to Lorraine and has two boys Rohit and Rahul.

Kevin Keough

Kevin Keough

Kevin Keough is the Principal of Kevin Keough Consulting Incorporated, a company providing analysis and strategic and operational advice on science and innovation. He also serves, part time, as the Executive Director of the Alberta Prion Research Institute. Prior to joining the Alberta Prion Research Institute, Dr. Keough held various senior positions within the research sector, including: President and CEO of the Alberta Heritage Foundation for Medical Research; the first Chief Scientist at Health Canada in Ottawa; and, the first Vice-President of Research and International Relations at Memorial University of Newfoundland. He is also co-founder, President and Chief Scientific Officer of NovaLipids Inc., and he is a Fellow of the Canadian Academy of Health Sciences.

Dr. Keough is Professor Emeritus of Biochemistry at Memorial University where he has had an active career in research for nearly fifty years. He headed a productive biochemical research laboratory at Memorial University for more than three decades, and has been active in research on biological membranes and lung surfactant for nearly fifty years. Dr. Keough is the author or co-author of 140 published scientific papers, one book, 190 presentations at scientific conferences, and 70 invited scientific presentations at national and international institutions and conferences.

Dr. Keough has been a member of the Boards of Directors and Governing Councils of a large number of agencies and not-for-profit corporations including the Medical Research Council of Canada, the Canadian Institutes of Health Research and Genome Canada. He is currently a member of the Boards of Directors of the Alberta Health Industry Association, and the Science Media Centre of Canada. He is a member of the External Advisory Council of Virtual Researchers on Call and Partners in Research. He is on the Governing Boards of two international research organizations, NeuroPrion and the Asia Pacific Society for Prion Research.

He has served as a consultant to national and international research organizations, the pharmaceutical industry and to various levels of government. Dr. Keough continues to participate in research activities and advising, and is frequently consulted on issues of science and innovation policy and management by academia, government and industry.

Marc Leroux

Marc Leroux

Marc Leroux is the Principal at Priorat Capital and has extensive experience in innovation and technology transfer through both the private and postsecondary research sectors. He is the former Managing Director of UNIVALOR LP, which is responsible for technology management and transfer for 10 research centres affiliated with the Université de Montréal, including École Polytechnique and six research hospitals, as well as the creation of spin-off companies and other business deals in all fields of university research. Marc Leroux has close to 40 years of experience in research and technology transfer, with a particular focus in the telecommunications industry. His areas of expertise include hands-on management in growth and turnaround situations, sales and business development, introducing technologies into markets, and creation and management of partnerships. Marc Leroux holds a Bachelor of Science degree from McGill University and a Master of Science from Institut National de la Recherche Scientifique (INRS). In recognition of his contributions to research and innovation in the Québec public sector, he was awarded the 2010 Bâtisseur prize by the Association pour le développement de la recherche et de l'innovation du Québec (ADRIQ). He is currently a member of Anges Québec and a member of the boards of directors for the Centre québecois d’incubation des biotechnologies (CQIB) and the Fondation des Étoiles (research in children’s diseases).

Martin Walker

Martin Walker

Martin Walker, media and entertainment technology executive, has been involved in commercial software development in Montreal from the mid 1980s. He has spent most of his career in the multimedia arena, working for companies like Matrox Electronics, Softimage, Behaviour and others. He has been a key player in building tools and environments for video productions including special effects and 3D computer graphics. His venture in the gaming industry has evolved into the creation of several generations of multiplatform game engines and the elaboration of optimized production pipelines to unleash the creative power of artists, designers and programmers on over 120 titles. Currently CTO for Fuel Industries, a youth engagement company specialising in brand gamification through mobile and web applications, Martin has been board executive for l’Alliance Numérique, and a member of advisory committees for Concordia University, Champlain College in Burlington, Université de Sherbrooke and Collège Bois-de-Boulogne to help improve art and game production programs.